New ALS Gene Discovered: KIF5A Answer ALS Shared Genomes Helped Lead to New Discovery NEW ORLEANS – March 22, 2018, ALS researchers have identified a new ALS gene: KIF5A. This important gene discovery will help all researchers understand ALS disease pathways and represents a potential new ALS therapeutic target. Answer ALS is proud to have…
Thursday, November 30, 2017 WARLICK’S WARRIORS RECEIVES $50,000 DONATION FROM AMERICAN AIRLINES Contribution to Honor Brian McMenamy, Retiring as Vice President – Finance DALLAS, Texas – American Airlines has gifted $50,000 to Warlick’s Warriors to honor of Brian McMenamy who is retiring after 33 years with American Airlines. He has served as Vice President –…
October 11, 2017 – Last week at the 2017 Annual NEALS Meeting, Answer ALS researchers presented updates on the initiative to the ALS research community. Those updates included some unprecedented efforts in the strategy to find answers and solutions to ALS. “When Answer ALS was envisioned and ultimately organized, we wanted the entire research community,…
American Airlines to Donate $1M to Answer ALS Foundation Oct 12, 2016 FORT WORTH, Texas, Sept. 20, 2016 (GLOBE NEWSWIRE) — American Airlines this year will begin a multi-year financial commitment of $1 million to the Answer ALS research project through the Answer ALS Foundation. The research project will build the most comprehensive clinical,…
Data & TechnologyHarnessing Big Data with Advanced Analytics Neuromine is one of the world’s most robust and comprehensive ALS data resources, integrating multi-omics, clinical, and cellular datasets, while also linking to coordinating iPSC lines, biosamples, and other large-scale data platforms with analytic tools to maximize discovery and collaboration.
Multi-Omnics AnalysisComprehensive Biological Data Integration Making a comprehensive multi-omics datasets available that integrates genomics, transcriptomics, proteomics, epigenomics, and iPSC-derived motor neuron data that is freely accessible for analysis.
IPS Cells & Motor NeuronsGenerated 1,000 Participant-Derived Cell Lines Learn More about how to access 1,000 iPSC lines through our partners at the Cedars-Sinai Biomanufacturing Center
Clinic & enrollmentLeading Clinics Engaged to Complete Enrollment Enrollment in the Answer ALS program is complete, but you can Learn More about connected programs like Champion Insights, ALS Therapy Development’s ARC Program
